Skip to main content
Clinical Trials/CTRI/2018/03/012788
CTRI/2018/03/012788
Completed
Phase 4

An observational analysis of clinical outcomes in patients of vernal keratoconjunctivitis treated with dual acting antihistamines and mast cell stabilisers.

All India Institute of Medical SciencesRishikesh0 sites60 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: H108- Other conjunctivitisHealth Condition 2: null- vernal keratoconjunctivitis
Sponsor
All India Institute of Medical SciencesRishikesh
Enrollment
60
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 31, 2019
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
All India Institute of Medical SciencesRishikesh

Eligibility Criteria

Inclusion Criteria

  • patients with a clinical diagnosis of vernal keratoconjunctivitis.
  • patients of either gender \> 5 years.
  • patients should be willing to consent for all required study visits and follow instructions from study investigators.

Exclusion Criteria

  • Patients who are in active stage of any other ocular inflammatory disease besides VKC
  • Presence of glaucoma, uveitis.
  • Patients on any oral or topical steroids.
  • Pregnant or lactating women.
  • Presence of systemic diseases other than co existing allergic rhinitis, asthma and atopic dermatitis
  • Any documented H/O hypersensitivity to the said drugs.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 1
Outcome measures in SMA patients treated with Risdiplam.Spinal Muscular Atrophy (SMA)MedDRA version: 20.1Level: PTClassification code: 10041582Term: Spinal muscular atrophy Class: 100000004850Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
CTIS2022-501760-17-00Z Leuven20
Completed
Not Applicable
Prospective assessment of the clinical outcome of patients with primary breast cancer who have been tested with the EndoPredict gene expression test - a prospective care research study (RESCUE, Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer)C50Malignant neoplasm of breast
DRKS00014051OGGO e.V.1,191
Completed
Not Applicable
Prospective Assessment of the Clinical Outcome of High Tibial OsteotomyHigh Tibial OsteotomyMusculoskeletal - OsteoarthritisSurgery - Other surgery
ACTRN12612001013853eo Pinczewski100
Not yet recruiting
Not Applicable
Information regarding global developmental delay in childreHealth Condition 1: G998- Other specified disorders of nervous system in diseases classified elsewhere
CTRI/2024/07/070863Seth GS Medical College and KEM Hospital
Recruiting
Not Applicable
Clinical observational study for evaluation of the therapy outcome and the dependency of the outcome on parameters as reconstruction type and/or vitamin D level in OMS tumor patients in need of intra-oral tumor resection and reconstructioC01C02C03C04C05C06C44C40C41C07C08C09C10C11C12C13C14Malignant neoplasm of base of tongueMalignant neoplasm of other and unspecified parts of tongueMalignant neoplasm of gumMalignant neoplasm of floor of mouthMalignant neoplasm of palateMalignant neoplasm of other and unspecified parts of mouthOther malignant neoplasms of skinMalignant neoplasm of bone and articular cartilage of limbsMalignant neoplasm of bone and articular cartilage of other and unspecified sitesMalignant neoplasm of parotid glandMalignant neoplasm of other and unspecified major salivary glandsMalignant neoplasm of tonsilMalignant neoplasm of oropharynxMalignant neoplasm of nasopharynxMalignant neoplasm of piriform sinusMalignant neoplasm of hypopharynxMalignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
DRKS00025841niversitätsklinikum derGoethe-Universität Frankfurt am MainKlinik für Mund-, Kiefer- und Plastische Gesichtschirurgie100